NEW YORK , Sept. 28, 2022 /PRNewswire/ -- The Insight Partners published latest research study on " Orthopedic Implants Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Application, End User, and Geography", the global orthopedic implants market size is expected to grow from $46.10 Billion in 2021 to $67.23 Billion by 2028; it is expected to grow at a CAGR of 5.6% from 2022 to 2028. Download Sample Brochure of Orthopedic Implants Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00024316/ Orthopedic Implants Market Report Scope, Segmentations, Regional & Country Scope: Report Coverage Details Market Size Value in US$ 46.10 Billion in 2021 Market Size Value by US$ 67.23 Billion by 2028 Growth rate CAGR of 5.6% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021 No. of Pages 150 Historical data available Yes Segments covered Product, Application, End User, and Geography Regional scope North America; Europe; Asia Pacific; Latin America; MEA Country scope US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends Companies Covered DJO Finance LLC; Johnson & Johnson (DePuy Synthes); Medtronic Plc; Zimmer Biomet Holdings, Inc.; Stryker Corporation; NuVasive, Inc.; CONMED Corporation; Smith and Nephew Plc; Arthrex, Inc.; Globus Medical, Inc.
Check out Jefferies Group Stock Picks » Download GuruFolio Report of Jefferies Group (Updated on 08/14/2022) Related Stocks: QQQ , WYNN , SPY , EMB , CNMD ,
CONMED (NYSE:CNMD) declares $0.20/share quarterly dividend, in line with previous.Forward yield 0.8%Payable Oct. 5; for shareholders of record Sept. 15; ex-div Sept.
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2022 to all shareholders of record as of September 15, 2022. About CONMED Corporation CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedi
Earlier today, CONMED Corporation (NYSE: CNMD ) agreed to acquire privately held Biorez Inc for $85 million and up to $165 million in commercial-based milestones. Biorez commercializes its BioBrace implant, a bioinductive scaffold used to reinforce soft tissue where weakness exists and promote soft tissue healing. Needham says that in the near term, Biorez is expected to be accretive to revenue growth and gross margins (Biorez''s gross margin is >80% vs. CNMD''s 2022E gross margin of ~55%). "In addition to becoming a significant growth driver over time, we expect BioBrace to function as a … Full story available on Benzinga.com
CONMED (CNMD) on Monday said it would acquire privately-held medical device start-up Biorez for a cash consideration of $85M at closing and up to an additional $165M in…
CONMED Corporation (NYSE:NYSE:CNMD) Q2 2022 Earnings Conference Call July 27, 2022 04:30 PM ET Company Participants Curt Hartman - Chairman, President & Chief Executive Officer Pat…
The following slide deck was published by CONMED Corporation in conjunction with their 2022 Q2 earnings call.
Conmed (NYSE: CNMD ) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings Conmed beat estimated earnings by 1.33%, reporting an EPS of $0.76 versus an … Full story available on Benzinga.com
CONMED press release (CNMD): Q2 Non-GAAP EPS of $0.76 beats by $0.01.Revenue of $277.19M (+23.1% Y/Y) beats by $2.97M.The Company lowered its revenue guidance for the full year 2022…
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2022. Second Quarter 2022 Highlights Sales of $277.2 million increased 8.6% year over year as reported and 9.8% in constant currency. Acquisitions contributed approximately 80 basis points of growth. Domestic revenue increased 3.9% year over year. International revenue increased 14.7% year over year as reported and 17.2% in constant currency. Diluted net loss per
PAC Capital Limited, the investment banking arm of PanAfrican Capital Holdings, has announced the successful completion of a $50 million construction and medical tourism relay facility (CONMED) landmark deal. Humphrey Oriakhi, managing director of PAC Capital, made this known in a statement after the deal was completed. Oriakhi said this was the first CONMED to […] read more PAC Capital closes $50m deal in Nigeria’s healthcare sector
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2022 after the market close on Wednesday, July 27, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed fro
Conmed Corp. (CNMD) shares closed today at 1.5% above its 52 week low of $87.62, giving the company a market cap of $2B. The stock is currently down 37.5% year-to-date, down 35.2% over the past 12 months, and up 81.7% over the past five years. This week, the Dow Jones Industrial Average fell 7.2%, and the S&P 500 fell 8.7%. Trading Activity Trading volume this week was 4.5% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 3.6% lower than its 5-day moving average, 16.5% lower than its 20-day moving average, and 32.3% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 118.7% The company's stock price performance over the past 12 months lags the peer average by 57.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 19.3% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Conmed (CNMD) completed the acquisition of the medical devices company In2Bones Global.
CONMED Corporation (NYSE:CNMD) shares, rose in value on Thursday, June 02, with the stock price up by 1.54% to the previous day’s close as strong demand from buyers drove the stock to $113.51. Actively observing the price movement in the recent trading, the stock is buoying the session at $111.79, falling within a range of … In 2022, Will CONMED Corporation (NYSE: CNMD) Be Bullish Or Bearish? Read More »
CONMED (CNMD) priced its $700M principal amount of 2.25% convertible senior notes due 2027 in a private offering to qualified institutional buyers.It granted a 13-day option to…
Major players in the market name: market are Fresenius Kabi AG, Nestle SA, Moog Inc, B. Braun Melsungen AG, Cardinal Health Inc, Danone, Conmed Corporation, Cook Medical, Becton Dickinson and Company, Abbott Laboratories, Boston Scientific, Vygon Group, Amsino International Inc. Major players in the market name: market are Fresenius Kabi AG, Nestle SA, Moog Inc, B. Braun Melsungen AG, Cardinal Health Inc, Danone, Conmed Corporation, Cook Medical, Becton Dickinson and Company, Abbott Laboratories, Boston Scientific, Vygon Group, Amsino International Inc.
Major players in the trocars market are Johnson & Johnson Medical Devices, B. Braun Melsungen AG, Medtronic, Teleflex Incorporated, CooperSurgical Inc, CONMED Corporation, Applied Medical Resources Corporation, LaproSurge, Purple Surgical, Unimax medical systems Inc, and Olympus Corporation. Major players in the trocars market are Johnson & Johnson Medical Devices, B. Braun Melsungen AG, Medtronic, Teleflex Incorporated, CooperSurgical Inc, CONMED Corporation, Applied Medical Resources Corporation, LaproSurge, Purple Surgical, Unimax medical systems Inc, and Olympus Corporation.
Major players in the gastrointestinal bleeding treatment devices market are CONMED, Boston Scientific Corporation, US Medical Innovations, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris Plc, and Pfizer Inc. Major players in the gastrointestinal bleeding treatment devices market are CONMED, Boston Scientific Corporation, US Medical Innovations, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris Plc, and Pfizer Inc.
This report studies the Orthopedic Bone Cement Material Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Orthopedic Bone Cement Material market segmented []
This report studies the Neurosurgery Surgical Power Tool Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Neurosurgery Surgical Power Tool market segmented []
This report studies the Bone Graft and Substitute Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Bone Graft and Substitute market segmented []
Rise in incidence of sports-related injuries, supportive government initiatives, and increase in awareness about physical fitness areanticipated toboost thegrowthoftheglobal sports medicine devicesmarket. The report offers an extensive analysis of the changing trends, key market segments, drivers and opportunities, competitive landscape,
The Insight Partners announces the research on Global Pediatric Craniosynostosis Treatment Market as it covers the key boundaries required for your Research Need. This Global Pediatric Craniosynostosis Treatment Market Report []
AllTheResearchs Global Minimally Invasive Gastrointestinal Surgical Systems Market Strategic recommendations, Trends, Segmentation, Use case Analysis, Competitive Intelligence, Global and Regional Forecast (to 2026) report provides an overview of the market size of Minimally Invasive Gastrointestinal Surgical Systems for the regions United States, Europe (France, Germany, Italy, Spain, UK) and Japan, etc. Based on the []
AllTheResearchs Global Surgical Sutures Market Strategic recommendations, Trends, Segmentation, Use case Analysis, Competitive Intelligence, Global and Regional Forecast (to 2026) report provides an overview of the market size of Surgical Sutures for the regions United States, Europe (France, Germany, Italy, Spain, UK) and Japan, etc. Based on the Surgical Sutures industrial chain, this report []
AllTheResearchs Global Surgical Equipment Market Strategic recommendations, Trends, Segmentation, Use case Analysis, Competitive Intelligence, Global and Regional Forecast (to 2026) report provides an overview of the market size of Surgical Equipment for the regions United States, Europe (France, Germany, Italy, Spain, UK) and Japan, etc. Based on the Surgical Equipment industrial chain, this report []
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, Meniscal Repair Systems Market: Global Opportunity Analysis and Industry Forecast 2020-2027. This market research study determines the increase in changes and the aspects which are likely to have an impact on
MRInsights.biz recently published a new report titled Global Rigid Medical Endoscopes Market Growth 2021-2026 which has been designed in a systematic pattern to understand various dynamics of the market to understand the definitive growth patterns in a top-bottom approach. The report details significant aspects that are impelling the progression of the Rigid Medical Endoscopes market. []
Global Sports Medicine Market The global Sports Medicine Market has been comprehensively analyzed and the results are presented in the market report published. The market concentration that is currently occupied by the Sports Medicine market and an overview of the Sports Medicine manufacturing industry is extensively researched in the report. An analysis of the collected []
This report studies the Orthopaedic Devices Market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Orthopaedic Devices Market analysis segmented by companies, region, type and applications []
The global Rigid Endoscopes market was valued at 2883.8 million in 2020 and is projected to reach US$ 3489.4 million by 2027, at a CAGR of 4.9% during the forecast period. Global Rigid Endoscopes Market Report 2021 comes with an extensive industry analysis of development components, patterns, flows, and sizes. The report also calculates present []
HTF MI released new intelligence report on Global Transbronchial Aspiration Needles Market aiming to deliver competitive advantage. The study discusses how various medical equipment manufacturers are reinventing their Transbronchial Aspiration Needles business and operating models with future outlook. Some of the Manufacturers considered in the study are Hobbs Medical, CONMED Corporation, Boston Scientific & Olympus etc. Get []
- ← Previous
- 1
- 2
- 3
- Next →